293 related articles for article (PubMed ID: 27339645)
1. [Role of neoadjuvant radiotherapy for rectal cancer : Is MRI-based selection a future model?].
Kulu Y; Hackert T; Debus J; Weber MA; Büchler MW; Ulrich A
Chirurg; 2016 Jul; 87(7):573-8. PubMed ID: 27339645
[TBL] [Abstract][Full Text] [Related]
2. [The optimult study concept - selective neoadjuvant chemoradiation therapy based on preoperative MRI].
Kreis ME; Junginger T; Rödel C; Heinemann V; Nikolaou K; Mansmann U; Jauch KW
Zentralbl Chir; 2010 Aug; 135(4):302-6. PubMed ID: 20806131
[TBL] [Abstract][Full Text] [Related]
3. Significance of MRI in rectal carcinoma therapy optimization - correlation of preoperative T- and N-staging with definitive histopathological findings.
Danihel L; Danihel L; Rajcok M; Mosna K; Belan V; Varga I; Schnorrer M
Neoplasma; 2019 May; 66(3):494-498. PubMed ID: 30793609
[TBL] [Abstract][Full Text] [Related]
4. [Lymph node metastases in ypT1/2 rectal cancer after neoadjuvant chemoradiotherapy : The Achilles heel of organ-preserving operative procedures?].
Sprenger T; Rothe H; Beissbarth T; Conradi LC; Kauffels A; Homayounfar K; Behnes CL; Rödel C; Liersch T; Ghadimi M
Chirurg; 2016 Jul; 87(7):593-601. PubMed ID: 27106241
[TBL] [Abstract][Full Text] [Related]
5. [The role of magnetic resonance imaging to select patients for preoperative treatment in rectal cancer].
Rödel C; Sauer R; Fietkau R
Strahlenther Onkol; 2009 Aug; 185(8):488-92. PubMed ID: 19652930
[TBL] [Abstract][Full Text] [Related]
6. The effects of chemoradiotherapy on recurrence and survival in locally advanced rectal cancers with curative total mesorectal excision: a prospective, nonrandomized study.
Akgun E; Ozkok S; Tekin M; Yoldas T; Caliskan C; Kose T; Karabulut B; Sezak M; Elmas N; Ozutemiz O
World J Surg Oncol; 2017 Nov; 15(1):205. PubMed ID: 29166925
[TBL] [Abstract][Full Text] [Related]
7. Long-term prognostic value of mesorectal grading after neoadjuvant chemoradiotherapy for rectal cancer.
Madbouly KM; Hussein AM; Abdelzaher E
Am J Surg; 2014 Sep; 208(3):332-41. PubMed ID: 24581995
[TBL] [Abstract][Full Text] [Related]
8. Clinically Node Negative, Pathologically Node Positive Rectal Cancer Patients Who Did Not Receive Neoadjuvant Therapy.
Akeel N; Lan N; Stocchi L; Costedio MM; Dietz DW; Gorgun E; Kalady MF; Karagkounis G; Kessler H; Remzi FH
J Gastrointest Surg; 2017 Jan; 21(1):49-55. PubMed ID: 27796635
[TBL] [Abstract][Full Text] [Related]
9. [Current MRI staging of rectal cancer].
Wietek BM; Kratt T
Rofo; 2012 Nov; 184(11):992-1001. PubMed ID: 22893486
[TBL] [Abstract][Full Text] [Related]
10. [Application of magnetic resonance in "non-operative treatment" strategy for rectal cancer].
Wang Y; Chen G
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jun; 20(6):630-634. PubMed ID: 28643307
[TBL] [Abstract][Full Text] [Related]
11. [Lymph node dissection after primary surgery and neoadjuvant radiochemotherapy of rectal cancer. Interim analysis of a multicenter prospective observational study (OCUM)].
Kreis ME; Maurer CA; Ruppert R; Ptok H; Strassburg J; Junginger T; Merkel S; Hermanek P
Chirurg; 2015 Dec; 86(12):1132-7. PubMed ID: 26223668
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant radiotherapy for rectal cancer management.
Feeney G; Sehgal R; Sheehan M; Hogan A; Regan M; Joyce M; Kerin M
World J Gastroenterol; 2019 Sep; 25(33):4850-4869. PubMed ID: 31543678
[TBL] [Abstract][Full Text] [Related]
13. Comparative Outcomes of Neoadjuvant Treatment Prior to Total Mesorectal Excision and Total Mesorectal Excision Alone in Selected Stage II/III Low and Mid Rectal Cancer.
Kulu Y; Tarantino I; Billeter AT; Diener MK; Schmidt T; Büchler MW; Ulrich A
Ann Surg Oncol; 2016 Jan; 23(1):106-13. PubMed ID: 26305025
[TBL] [Abstract][Full Text] [Related]
14. MAGNETIC RESONANCE IMAGING TO EVALUATE NEOADJUVANT THERAPY EFFECTS ON RECTAL CARCINOMA.
Sofić A; Vukobrat-Bijedić Z; Husić-Selimović A; Šehović N; Buija D; Eminagić D; Banjin M; Đuran A
Acta Clin Croat; 2015 Sep; 54(3):303-8. PubMed ID: 26666099
[TBL] [Abstract][Full Text] [Related]
15. Surgery for locally recurrent rectal cancer in the era of total mesorectal excision: is there still a chance for cure?
Rahbari NN; Ulrich AB; Bruckner T; Münter M; Nickles A; Contin P; Löffler T; Reissfelder C; Koch M; Büchler MW; Weitz J
Ann Surg; 2011 Mar; 253(3):522-33. PubMed ID: 21209587
[TBL] [Abstract][Full Text] [Related]
16. Resectable rectal cancer: which patient does not need preoperative radiotherapy?
Kulu Y; Ulrich A; Büchler MW
Dig Dis; 2012; 30 Suppl 2():118-25. PubMed ID: 23207943
[TBL] [Abstract][Full Text] [Related]
17. Rectal cancer threatening or affecting the prostatic plane: is partial prostatectomy oncologically adequate? Results of a multicentre retrospective study.
Frasson M; Garcia-Granero E; Parajó A; Garcia-Mayor L; Flor B; Garcia-Granero A; Lavery I
Colorectal Dis; 2015 Aug; 17(8):689-97. PubMed ID: 25735444
[TBL] [Abstract][Full Text] [Related]
18. New aspects of adjuvant radiotherapy in primarily resectable rectal cancer.
Budach W
Onkologie; 2002 Jun; 25(3):223-30. PubMed ID: 12119456
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of circumferential resection margin following total mesorectal excision and adjuvant chemoradiotherapy in patients with rectal cancer.
Baik SH; Kim NK; Lee YC; Kim H; Lee KY; Sohn SK; Cho CH
Ann Surg Oncol; 2007 Feb; 14(2):462-9. PubMed ID: 17096053
[TBL] [Abstract][Full Text] [Related]
20. Use of Preoperative Magnetic Resonance Imaging to Select Patients with Rectal Cancer for Neoadjuvant Chemoradiation--Interim Analysis of the German OCUM Trial (NCT01325649).
Kreis ME; Ruppert R; Ptok H; Strassburg J; Brosi P; Lewin A; Schön MR; Sauer J; Junginger T; Merkel S; Hermanek P;
J Gastrointest Surg; 2016 Jan; 20(1):25-32; discussion 32-3. PubMed ID: 26556476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
